baber/WOPTO huggingface dataset:
Patent AU-2017239417-A1 (AU)
Title: Semi-mobile self-standing building superstructure with self-insulating electricity-accumulating evacuated volume
Inventor: CHAVANNE BRUNO
IPC: E04B1/74
Filed: 2017-02-21
Abstract: Self-standing and self-insulating* building superstructure, the overall internal volume (1) of which is filled with rigid lightweight granules in which the rooms (2) of the dwelling are immersed. The loose-fill lightweight granules are spherical in shape, porous and free of binder. A removable skin made of gastight plasticised board clads the entire superstructure externally and internally. Gastight bay units are set into each window recess. The entire volume delimited by the gastight skin and the bay units is under vacuum, controlled by a vacuum pump (10). The outer skin and the internally ribbed internal walls are braced by the volume of granules rigidified by atmospheric pressure. A superposition of metallised films covered with ionic polarisation layers is inserted under the impervious skin. The ionic layers and electrolytic films, under vacuum, constitute supercapacitors or electrochemical accumulator cells. The building can be erected/dismantled infinitely. *Self-insulating: thermally insulating, noise-insulating, seismically insulating, electromagnetically insulating, Aqua-insulating.
Patent AU-2017247607-A1 (AU)
Title: Novel peptides and combination of peptides for use in immunotherapy against AML and other cancers
Inventor: MAHR ANDREA
IPC: C07K7/06
Filed: 2017-04-05
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent AU-2017256767-A1 (AU)
Title: Protein based excipient for active pharmaceutical ingredients
Inventor: VERGAUWEN BJORN
IPC: A61K47/34
Filed: 2017-04-28
Abstract: Provided herein is a pharmaceutical formulation comprising a protein based excipient in combination with an active pharmaceutical ingredient (API) wherein said formulation is substantially amorphous and form a substantially homogenous mixture; and further a method for producing said pharmaceutical formulation; and said pharmaceutical formulation for use as a medicament.
Patent AU-2017262858-A1 (AU)
Title: Building material comprising a polyolefin mesh
Inventor: CHAROENPINIJKARN WISSANEE
IPC: E04C2/04
Filed: 2017-05-09
Abstract: The present invention related to a building material comprising a polyolefin mesh, wherein the polyolefin mesh is arranged inside the building material and/or on at lest one surface thereof. The building material has advantages of improved strength, lighter weight, easy installation and transportation, low cost of material and installation.
Patent AU-2017277631-A1 (AU)
Title: Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA
Inventor: KAMEI DANIEL TAKASHI
IPC: G01N33/53
Filed: 2017-06-07
Abstract: In various embodiments methods and devices are provided for the detection and/or quantification of an analyte. In certain embodiments a device is provided comprising an aqueous two-phase system (ATPS) comprising a mixed phase solution that separates into a first phase solution and a second phase where, in use, said first phase solution becomes a leading phase and said second phase solution becomes a lagging phase; a lateral-flow assay (LFA); and a probe and/or a development reagent, where in use, said probe associates with said first phase solution in said leading phase of said ATPS and/or said development reagent associates with said second phase solution in said lagging phase of said ATPS. In certain embodiments a "one-pot" system of purifying and amplifying a nucleic acid is provided utilizing, e.g., an ATPS and isothermal amplification reagents.
Patent AU-2017279700-A1 (AU)
Title: Data transmission method and apparatus
Inventor: ZHANG SHUNQING
IPC: H04B7/06
Filed: 2017-12-20
Abstract: According to a data transmission method and an apparatus provided in the present invention, sparse code codebooks that can be used by a base station in a coordinating cluster in data transmission with a terminal are mutually different. This implements that base stations separately perform data transmission with the terminal without performing data exchange or channel information exchange between the base stations, thereby reducing system overheads and improving network transmission efficiency. A base station receives a codebook instruction sent by a controller The base station sends a codebook notification to a terminal The base station uses a coordination codebook to perform data transmission with the terminal A controller determines a coordinating cluster The controller sends a codebook instruction to each base station in the coordinating cluster A terminal receives a codebook notification sent by a base station in a coordinating cluster The terminal uses a coordination codebook notified in the codebook notification to perform data transmission with the base station
Patent AU-2017281285-A1 (AU)
Title: Heterocyclic compounds as immunomodulators
Inventor: XIAO KAIJIONG
IPC: C07D513/04
Filed: 2017-06-19
Abstract: Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
Patent AU-2017281938-A1 (AU)
Title: Unique token authentication cryptogram
Inventor: CASSIN Michael
IPC: H04L9/32
Filed: 2017-06-23
Abstract: Embodiments of the invention are directed to systems and methods for validating transactions using a cryptogram. One embodiment of the invention is directed to a method of processing a remote transaction initiated by a communication device provisioned with a token. The method comprises receiving, by a service provider computer, from an application on the communication device, a request for a token authentication cryptogram, wherein the token authentication cryptogram includes encrypted user exclusive data. The service provider computer may generate the token authentication cryptogram to include the user exclusive data. The service provider computer may send the token authentication cryptogram to the application, where the token authentication cryptogram can be used to validate the transaction, and the user exclusive data is extracted from the token authentication cryptogram during validation.
Patent AU-2017283496-A1 (AU)
Title: Modular device for cell spraying
Inventor: BHOGAL JATINDER S
IPC: B05B7/02
Filed: 2017-06-13
Abstract: Systems and methods for spraying a liquid treatment solution include a syringe attachment device and a handheld device. The syringe attachment device can be configured to secure a syringe containing the liquid treatment solution. The handheld device can have a movable slide configured to dispense the treatment solution from the syringe. The spray deposition system can include a cover' positioned to provide an impervious barrier between at least a portion of the syringe attachment device and the handheld device. The cover can be attached to the syringe attachment device prior to coupling the devices together. In an example, the cover can have a generally tubular shape with a closed end and an open end. The handheld device can be inserted into the cover and the cover can enclose the handheld device in the assembled position. In an example, the cover can be sterile and at least a portion of the syringe attachment device can be sterile.
Patent AU-2017320337-A1 (AU)
Title: Apparatus for supporting an explosive device
Inventor: REDFERN ANTHONY
IPC: F42D3/04
Filed: 2017-08-30
Abstract: An apparatus (1) for supporting an explosive device (13) including a base member (3), one or more support members (11) and a fluid aperture (19). The base member (3) includes a base member aperture (5) to provide a passage (7) to a base chamber (9) of the base member (3). The one or more support members (11) are telescopically receivable through the base member aperture (5) and into the base chamber (9), wherein the one or more support members (11) support the explosive device (13). The fluid aperture (19) allows pressurised fluid into the base chamber (9) to force the one or more support members (11) towards an extended configuration (23) such that at least part of the one or more support members (11) are telescopically extended out of the base chamber (9).
Patent AU-2017321445-A1 (AU)
Title: Cartridge for water purifier, and water purifier
Inventor: TAKAGI TOSHIO
IPC: C02F1/28
Filed: 2017-08-09
Abstract: Provided is a cartridge 4 for a water purifier, the cartridge 4 being configured so as to prevent the breakage of activated carbon 8 caused by water hammer or high water pressure occurring when raw water discharge is switched to purified water discharge. This cartridge 4 for a water purifier is accommodated in a replaceable manner within the accommodation section 5 of the water purifier 1. The cartridge 4 has activated carbon 8 for removing impurities from water. The water purifier 1 has formed therein: a raw water flow passage through which raw water flows downstream without passing through the activated carbon 8; and a purified water flow passage through which raw water flows downstream, passing through the activated carbon 8. The water purifier 1 has a damping section 10d located downstream of the activated carbon 8 and upstream of flow passage switching valves 15, 16 for switching between discharge from the raw water flow passage and discharge from the purified water flow passage, the damping section 10d preventing water hammer from the flow passage switching valves 15, 16 from acting on the activated carbon 8.
Patent AU-2017325804-A1 (AU)
Title: Therapeutic compression apparatus and methods of use
Inventor: RAVIKUMAR SUNDARAM
IPC: A61H7/00
Filed: 2017-08-23
Abstract: A therapeutic compression apparatus for providing pressure to a limb or other body part including a bladder assembly having at least one bladder within, a primary wrap and/or a secondary wrap. The primary wrap includes an inflation port to connect to an inflation means which provides either constant or varying pressure within the bladder and a check valve is included in the inflation port and/or inflation means.
Patent AU-2017327663-A1 (AU)
Title: Modified VSV-G and vaccines thereof
Inventor: VANDERMEULEN GAËLLE
IPC: A61K39/00
Filed: 2017-09-14
Abstract: The present invention relates to modified vesicular stomatitis virus glycoprotein (VSV-G) comprising at least one peptide, preferably an antigen or fragment thereof, nucleic acid sequence coding therefor, and vectors containing said nucleic acid sequence. The present invention also relates to vaccines and methods for the treatment of a disease or condition, in particular a cancer or an infectious disease.
Patent AU-2017333801-A1 (AU)
Title: Method of Producing Lipid
Inventor: OZAKI TATSURO
IPC: C12P7/64
Filed: 2017-09-22
Abstract: Provided is a lipid manufacturing method in which transformants into which are introduced genes coding for at least one protein selected from a group formed of proteins (A)-(C), described below, are cultured and in which fatty acids or lipids including said fatty acids as constituent components are caused to be produced. Also provided are transformants having the genes coding for at least one protein selected from the group formed of the proteins (A)-(C), described below. (A) A protein formed of the amino acid sequence at positions 23-146 in SEQ ID NO: 1. (B) A protein that is formed of an amino acid sequence that is identical, at 70% or greater, to the amino acid sequence of the protein (A) and that exhibits acyl carrier protein activity. (C) A protein that has the amino acid sequence of the protein (A) or (B) and that exhibits acyl carrier protein activity.
Patent AU-2017347911-A1 (AU)
Title: Method and apparatus for programmable, real-time, multi-domensional object pattern recognition algorithms (OPRA)
Inventor: CROSETTO DARIO
IPC: G16C10/00
Filed: 2017-10-30
Abstract: The present 3D-Flow OPRA is a revolutionary electronic instrument for multiple applications: advancing science, saving lives, finding and tracking fast moving objects, etc. It allows to build a flexible, scalable, technology-independent, cost effective powerful tool to uncover the unknown and to confirm or exclude the existence of a subatomic particle predicted by theoretical physicists. When used for Medical Imaging applications the 3D-Flow OPRA allows to accurately measure minimum abnormal biological processes of diseases at an early curable stage such as cancer in a 3D-CBS (3-D Complete Body Screening), improving diagnosis and prognosis to maximize reduction of premature deaths and minimize cost per each life saved. Both instruments, the 3D-Flow OPRA and the 3DCBS can benefit from the additional ER/DSU invention also described in this non-provisional patent application, which allows to record real data from detectors.
Patent AU-2017348287-A1 (AU)
Title: Polymer compositions with PBSA plasticizer
Inventor: JOHNSON ADAM
IPC: C08L67/02
Filed: 2017-10-27
Abstract: A polymeric composition is disclosed which includes from about 40 to about 99 weight percent of a first polymer and from about 1 to about 60 weight percent of polybutylene(succinate-co-adipate) ("PBSA"). Preferably the first polymer is selected from the group consisting of polyvinyl chloride, polylactic acid, polyhydroxy alkanoates, and mixtures thereof. A method for making the composition is also disclosed.
Patent AU-2017353112-A1 (AU)
Title: Drive configuration
Inventor: FLAXMAN ROBERT JOHN BONNER
IPC: B60K17/08
Filed: 2017-09-01
Abstract: A drive configuration for a skid-steered vehicle comprising: a pair of traction motors (102) for rotationally driving opposite outputs of the drive configuration, the traction motors being operatively connected to the outputs (113) via respective gearing arrangements (104) for selectively varying gear reduction between each of the traction motors and the corresponding output; a steer differential (110) in a torque connection with the first and second outputs of the drive configuration; and a steer motor (106) operatively connected to the steer differential for selectively varying the rotational speed of the first and second outputs in use; wherein the traction and steer motors define a volume in which the gearing arrangements and steering differential are at least partially located.
Patent AU-2017439374-A1 (AU)
Title: Filter bags comprising a porous membrane
Inventor: ROEHMER REBECCA
IPC: B01D39/16
Filed: 2017-11-13
Abstract: A filter bag is disclosed that comprises a porous membrane having a strength in the transverse direction to improve durability. There is a filter assembly for filtering particulates from a gas stream comprising a support substructure and a filter bag at least partially surrounding the support substructure. The filter bag comprises a porous membrane having a upstream surface exposed to the gas stream. The porous membrane is lightweight and has a structure to collect the particulates on the upstream surface. In particular, the porous membrane has a bubble point of 0.06 MPa or more and has a strength in a transverse direction that is 100 N/m or more. Other filter bags disclosed comprise a laminate comprising a porous membrane having a bubble point of 0.06 MPa or more and a second layer that acts as a sacrificial material.
Patent AU-2018200138-A1 (AU)
Title: A Composition For Treating Diabetes or Diabesity Comprising Oxyntomudulin Analog
Inventor: KIM JIN SUN
IPC: C07K14/605
Filed: 2018-01-08
Abstract: The present invention relates to a composition for preventing or treating diabetes, disbesity or diabetic complications, comprising an oxyntomodulin analog as an active ingredient. The invention also relates to a method for treating diabetes, diabesity or diabetic complications, comprising administering a pharmaceutically effective amount of an oxyntomodulin analog to a subject. The oxyntomodulin analog has a high ability to activate the GLP-1 receptor and the glucagon receptor, compared to native oxyntomodulin. The oxyntomodulin analog induces the expansion of beta-cells and increases insulin secretion, thereby reducing blood glucose levels that were increased due to a high-calorie and high-fat diet. The oxyntomodulin analog induces decreases in body weight and diet intake to improve insulin sensitivity and allow blood glucose levels, which are not controlled due to insulin resistance, to be maintained at normal levels. Thus, the oxyntomoduin analog can be effectively used to prevent or treat of diabetes and related diseases. m Vehicle 0 Victoza 60rnolIkg(Dietes) M Victoza 10nmolIkg(Obesity) W Seq ID No.23-Fc conjugate 15nmollkg M Seq ID No.25-Fc conjugate Snmollkg -200 -U WO 2014/073845 PCT/KR2013/009990 [Fig. 4] Vehicle Victoza 6rmollkg(Diabetes) Victoza 100lnmol/kg(Obesity) Seq ID No.23-Fc conjugate 15nmol/kg Seq ID No.25-Fc conjugate 6nmol/kg > 20000 1 15000 i S10000-
Patent AU-2018200404-A1 (AU)
Title: Funery construction for containing funerary objects
Inventor: ROSSI FILIPPO
IPC: E04H13/00
Filed: 2018-01-17
Abstract: FUNERARY CONSTRUCTION FOR CONTAINING FUNERARY A funerary construction for containing funerary objects (1), which comprises a supporting structure (2) with at least one cavity (3) defined for accommodating at least one funerary object; the accommodation cavity (3) has at least one access opening which is closed by at least one closing plate (6) fixed to the supporting structure; at least one covering slab (10) is arranged facing the closing plate and there are elements of mounting (11) the covering slab on the supporting structure; the mounting elements (11) comprise at least one mounting element that is supported by the closing plate (6) and which defines at least one region (12) for resting the covering slab (10). - 4 10 "-4 16b 32 17 * 16 if 1b e3a 1~/'c). *
Patent AU-2018202958-A1 (AU)
Title: Stern platform assembly for an outboard propelled boat
Inventor: FURLAN ANDREA
IPC: B63H20/02
Filed: 2018-04-30
Abstract: Stern platform assembly for an outboard propelled boat A stern platform assembly for an outboard propelled boat, comprising a pair of side support wings, a movable platform arranged adjacent to the side support wings, and a motion mechanism housed within each of the side support wings and carrying the movable platform, wherein the movable platform is movable between a terminal elevation position, in which it is arranged adjacent to the top of the side support wings, and a terminal lowering position, while keeping a predetermined orientation with respect to the side support wings and keeping a closeness relationship with them, and wherein, when viewed in plan view, the assembly encompasses a room circumscribed on three sides by the movable platform and by the side support wings. (Figure 1) w U)
Patent AU-2018204761-A1 (AU)
Title: Control system for actuating drill pipe rack
Inventor: HUDSON CHARLES TAYLOR
IPC: E21B44/00
Filed: 2018-06-29
Abstract: Abstract CONTROL SYSTEM FOR ACTUATING DRILL PIPE RACK A control system (500) for actuating a drill pipe rack (200) is provided. The drill pipe rack (200) moves between a first position and a second position. The control system (500) includes a first actuator (214) to actuate a top end of the drill pipe rack (200) and a second actuator (216) to actuate a bottom end of the drill pipe rack (200). The control system (500) includes a pump to supply pressurized fluid to the first actuator (214) and the second actuator (216). The control system (500) further includes at least one volumetric flow divider in fluid communication with the pump. The volumetric flow divider is configured to supply equal volumetric quantity of the pressurized fluid to the first actuator (214) and the second actuator (216), and subsequently move the drill pipe rack (200) between the first position and the second position. 17-0175-67767 3/5 208 ( 104
Patent AU-2018209865-A1 (AU)
Title: Moving robot and method of controlling the same
Inventor: JANG JAEWON
IPC: A47L9/28
Filed: 2018-01-19
Abstract: A method of controlling a moving robot is provided. The method of controlling a moving robot includes the steps of: (a) performing a basic motion of the moving robot which moves on a rotating mop; (b) measuring the slip rate of the moving robot; and (c) controlling the travel of the moving robot.
Patent AU-2018222921-A1 (AU)
Title: Compositions and methods for the treatment of neurodegenerative and other diseases
Inventor: REEDER THADDUES CROMWELL
IPC: A61P25/28
Filed: 2018-08-28
Abstract: In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine.
Patent AU-2018226475-A1 (AU)
Title: Operation plan creation apparatus, operation plan creation method, and program
Inventor: YOSHIDA TAKUFUMI
IPC: G06Q50/06
Filed: 2018-09-06
Abstract: An operation plan creation apparatus as an aspect of the present invention creates an operation plan showing at least operation state change timing and maintenance implementation 5 timing as a target a facility or equipment having a tendency that the number of times of maintenance increases as the number of change times of an operation state increases. The operation plan creation apparatus includes a frequency determiner and a timing determiner. The frequency determiner determines an operation state change 10 frequency and a maintenance implementation frequency in a consideration term so as to reduce the sum of an operation cost and a maintenance cost of the target in the consideration term. The timing determiner determines operation state change timing and maintenance implementation timing in each section in the 15 consideration term so as to satisfy the operation state change frequency and the maintenance implementation frequency in the consideration term. H-D LUcC <at- LUH LU LUr <L4 Z> <c Lt0IL U m ____ 0 PRLIry < C n- cc Z cc LiL UU zcC C i=~ 0 ZL =z= p n C < -a- < Uo< cc LL - J C) Cl_ LUI o 2 :7C H- 0<
Patent AU-2018228786-A1 (AU)
Title: Personalised immunogenic peptide identification platform
Inventor: LISZIEWICZ JULIANNA
IPC: G01N33/569
Filed: 2018-03-02
Abstract: The disclosure relates to methods of identifying fragments of a polypeptide that are immunogenic for a specific human subject, methods of preparing personalised pharmaceutical compositions comprising such polypeptide fragments, human subject-specific pharmaceutical compositions comprising such polypeptide fragments, and methods of treatment using such compositions. The methods comprise identifying a fragment of the polypeptide that binds to multiple HLA of the subject.